Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
| December 31, | September 30, | |||||||
| 2007 | 2007 | |||||||
| rounded in thousands, except par value | (unaudited) | |||||||
Assets |
||||||||
Current Assets: |
||||||||
Cash |
$ | 334,000 | $ | 2,388,000 | ||||
Accounts receivable, net |
3,326,000 | 305,000 | ||||||
Inventories |
1,924,000 | 2,635,000 | ||||||
Other current assets |
409,000 | 365,000 | ||||||
Total Current Assets |
5,993,000 | 5,693,000 | ||||||
Equipment, furniture and fixtures at cost, less accumulated
depreciation of $121,000 and $108,000 |
202,000 | 215,000 | ||||||
Total Assets |
$ | 6,195,000 | $ | 5,908,000 | ||||
Liabilities and Shareholders Equity |
||||||||
Current Liabilities: |
||||||||
Accounts payable |
$ | 772,000 | $ | 892,000 | ||||
Accrued expenses |
105,000 | 123,000 | ||||||
Accrued payroll and related taxes |
178,000 | 151,000 | ||||||
Total Current Liabilities |
1,055,000 | 1,166,000 | ||||||
Commitments and contingencies (Note 8) |
||||||||
Shareholders Equity: |
||||||||
Preferred shares, $0.001 par value, 5,000 shares
authorized, 0 shares issued and outstanding |
| | ||||||
Common shares, $0.001 par value, 50,000 shares authorized
as of December 31, 2007 and September 30, 2007;
19,952,000 shares issued as of December 31, 2007 and
September 30, 2007; 19,839,000 shares outstanding as of
December 31, 2007 and September 30, 2007 |
20,000 | 20,000 | ||||||
Additional paid-in capital |
23,427,000 | 23,341,000 | ||||||
Accumulated deficit |
(18,001,000 | ) | (18,313,000 | ) | ||||
| 5,446,000 | 5,048,000 | |||||||
Less treasury stock, at cost, 113,000 shares as of
December 31, 2007 and September 30, 2007 |
(306,000 | ) | (306,000 | ) | ||||
Total Shareholders Equity |
5,140,000 | 4,742,000 | ||||||
Total Liabilities and Shareholders Equity |
$ | 6,195,000 | $ | 5,908,000 | ||||
See notes to unaudited condensed consolidated financial statements.
1
Table of Contents
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three months ended | ||||||||
| December 31, | ||||||||
| 2007 | 2006 | |||||||
| rounded in thousands, except per share amounts | (unaudited) | |||||||
Revenues |
$ | 3,561,000 | $ | 916,000 | ||||
Cost of goods sold |
1,806,000 | 202,000 | ||||||
Gross profit |
1,755,000 | 714,000 | ||||||
Selling, general and administrative |
1,317,000 | 974,000 | ||||||
Engineering, research and development |
139,000 | 159,000 | ||||||
Income (loss) from operations |
299,000 | (419,000 | ) | |||||
Other income/(expense): |
||||||||
Interest income |
13,000 | 14,000 | ||||||
Interest expense |
| (1,000 | ) | |||||
Income (loss) before provision for income taxes |
312,000 | (406,000 | ) | |||||
Income tax provision |
| | ||||||
Net income (loss) |
$ | 312,000 | $ | (406,000 | ) | |||
Net income (loss) per share: |
||||||||
Basic |
$ | 0.02 | $ | (0.02 | ) | |||
Fully-diluted |
$ | 0.01 | $ | (0.02 | ) | |||
Weighted average shares outstanding: |
||||||||
Basic |
19,839,000 | 16,875,000 | ||||||
Fully-diluted |
20,997,000 | 16,875,000 | ||||||
See notes to unaudited condensed consolidated financial statements.
2
Table of Contents
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three months ended | ||||||||
| December 31, | ||||||||
| 2007 | 2006 | |||||||
| Rounded in thousands | (unaudited) | |||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | 312,000 | $ | (406,000 | ) | |||
Adjustments
to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization |
13,000 | 4,000 | ||||||
Provision for bad debts |
(21,000 | ) | | |||||
Non-cash compensation to employees and directors |
84,000 | 248,000 | ||||||
Non-cash compensation to consultants |
2,000 | 33,000 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(3,000,000 | ) | 1,522,000 | |||||
Inventories, net |
711,000 | (82,000 | ) | |||||
Other current assets |
(44,000 | ) | (266,000 | ) | ||||
Accounts payable |
(120,000 | ) | (139,000 | ) | ||||
Accrued expenses |
(18,000 | ) | (1,000 | ) | ||||
Accrued payroll and related taxes |
27,000 | 53,000 | ||||||
Net cash
provided by (used in) operating activities |
(2,054,000 | ) | 952,000 | |||||
Cash flows from investing activities: |
||||||||
Purchases of equipment, furniture and fixtures |
| (34,000 | ) | |||||
Net cash used in investing activities |
| (34,000 | ) | |||||
Cash flows from financing activities: |
||||||||
Proceeds in connection with the exercise of warrants |
| 196,000 | ||||||
Proceeds in connection with stock subscription |
| 650,000 | ||||||
Net cash provided by financing activities |
| 846,000 | ||||||
Net increase (decrease) in cash |
(2,054,000 | ) | 1,778,000 | |||||
Cash, beginning of period |
2,388,000 | 99,000 | ||||||
Cash, end of period |
$ | 334,000 | $ | 1,877,000 | ||||
Supplemental cash flow information: |
||||||||
Cash paid during the period for income taxes |
$ | | $ | | ||||
Cash paid during the period for interest |
$ | | $ | 1,000 | ||||
See notes to unaudited condensed consolidated financial statements.
3
Table of Contents
NOTES TO UNUADITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(rounded in thousands)
(rounded in thousands)
1. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America for
interim financial information and pursuant to the rules and regulations of the Securities and
Exchange Commission (SEC). Accordingly, they do not include all of the information and footnotes
required by accounting principles generally accepted in the United States of America for complete
financial statements. In the opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation have been included. These
financial statements and notes thereto should be read in conjunction with the financial statements
and notes thereto for the year ended September 30, 2007 included in the Xenonics Holdings, Inc.
(Holdings) Form 10-KSB filing. The results for the interim period are not necessarily indicative
of the results for the full fiscal year.
The condensed consolidated financial statements include the accounts of Holdings and its
subsidiary Xenonics, Inc. (Xenonics), collectively, the Company. On December 14, 2004, one
warrant holder of Xenonics exercised his warrant to purchase 125,000 shares of Xenonics, Inc. As a
result, Holdings currently owns 98.6% of the issued and outstanding capital stock of Xenonics. All
significant inter-company items have been eliminated upon consolidation.
2. REVENUE RECOGNITION
The Company recognizes revenue net of discounts upon shipment and when it has evidence that
arrangements exist, the price to the buyer is fixed through signed contracts or purchase orders and
collection is reasonably assured. Customers do not have the right to return product unless it is
damaged or defective.
3. EARNINGS PER SHARE
Earnings per share is computed by dividing the income available to common shareholders by the
weighted average number of common shares outstanding. Diluted earnings per share is computed
similarly to basic earnings per share, except that the denominator is increased to include the
number of additional common shares that would have been outstanding if the potential additional
common shares that were dilutive had been issued. Common share equivalents are excluded from the
computation if their effect is anti-dilutive. The Companys common share equivalents consist of
stock options and warrants.
4
Table of Contents
The following table represents a reconciliation of the shares used to calculate basic and
diluted earnings per share for the respective periods indicated:
| Three Months Ended | ||||
| December 31, 2007 | ||||
Numerator: Net income |
$ | 312,000 | ||
Denominator: |
||||
Denominator for basic earnings per share weighted average shares |
19,839,000 | |||
Effect of dilutive securities
|
||||
Effect of dilutive securities
|
||||
Employee stock options |
1,158,000 | |||
Denominator for diluted earnings per share adjusted weighted
average shares and assumed conversion |
20,997,000 | |||
Basic earnings per share |
$ | 0.02 | ||
Diluted earnings per share |
$ | 0.01 | ||
For the three months ended December 31, 2006, the fully diluted loss per share did not include
the dilutive effect, if any, from the potential exercise of stock options and warrants using the
treasury stock method, because the effect would have been anti-dilutive.
Common shares from exercise of certain options and warrants have been excluded from the
computation of diluted earnings per share because their exercise prices are greater than the
Companys weighted-average stock price for the period. For the three months ended December 31,
2007, the number of shares excluded was 3,432,000.
Since their effect would have been, anti-dilutive, 1,495,000, stock options and warrants to
purchase shares of common stock have been excluded from the computation of diluted net loss per
share for the three months ended December 31, 2006.
4. INVENTORIES
Inventories were comprised of :
| December 31, | September 30, | |||||||
| 2007 | 2007 | |||||||
| (unaudited) | ||||||||
Raw materials |
$ | 904,000 | $ | 805,000 | ||||
Work in process |
231,000 | 228,000 | ||||||
Finished goods |
789,000 | 1,602,000 | ||||||
| $ | 1,924,000 | $ | 2,635,000 | |||||
5. USE OF ESTIMATES
The preparation of financial statements, in conformity with accounting principles generally
accepted in the United States of America, requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and
liabilities, at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.
5
Table of Contents
6. STOCK BASED COMPENSATION
Stock Options On October 1, 2006 the Company adopted SFAS No. 123 (revised 2004),
Share-Based Payment (SFAS 123R). SFAS 123R replaced SFAS No. 123 and supercedes APB Opinion No.
25. SFAS 123R requires all share-based payments to employees, including grants of employee stock
options, to be recognized in the financial statements based on their fair values. Prior to October
1, 2006, the Company used the fair value based method of accounting for share-based compensation
provided to employees in accordance with SFAS No. 123, Accounting for Stock-Based Compensation,
therefore adoption of SFAS 123R had no effect on the financial statements.
In July 2003, the Companys board of directors adopted a stock option plan. Under the 2003
option plan, options to purchase up to 1,500,000 shares of common stock are available for
employees, directors, and outside consultants.
In December 2004, the Companys board of directors adopted a 2004 stock incentive plan. The
Company may issue up to 1,500,000 shares of common stock under the 2004 plan and no person may be
granted awards during any twelve-month period that cover more than 300 shares of common stock.
The fair value of each option award is estimated on the date of grant using a Black-Scholes
valuation model. The following assumptions were used for options granted in the three months ended
December 31, 2007 and 2006:
| For the Three Months | ||||||||
| Ended December 31, | ||||||||
| 2007 | 2006 | |||||||
Risk-free interest rate |
4.16 | % | 4.60 | % | ||||
Expected life (in years) |
4 | 4 | ||||||
Dividend yield |
0.0 | % | 0.0 | % | ||||
Expected volatility |
105 | % | 99 | % | ||||
Weighted-average volatility |
105 | % | 99 | % | ||||
Expected volatility is determined based on historical volatility. Expected life is determined
based on historical experience of similar awards, giving consideration to the contractual terms of
the stock-based awards and vesting schedules. The risk-free interest rate is based on the U.S.
Treasury yield curve in effect at the time of grant. Share-based compensation expense recognized is
based on the options ultimately expected to vest, reduced by estimated forfeitures. SFAS 123R
requires forfeitures to be estimated at the time of grant and revised, if necessary in subsequent
periods if actual forfeitures differ from those estimated. Forfeitures were estimated based on the
Companys historical experiences.
6
Table of Contents
A summary of the Companys stock option activity as of December 31, 2007, and changes during
the three months then ended is presented below:
| Weighted | ||||||||||||||||
| Weighted | Average | |||||||||||||||
| Stock | Average | Contractual | Aggregate | |||||||||||||
| Options | Exercise Price | Term | Intrinsic Value * | |||||||||||||
Outstanding at October 1, 2007 |
1,988,000 | $ | 2.52 | 3.75 | ||||||||||||
Granted |
25,000 | $ | 2.02 | 4.76 | ||||||||||||
Exercised |
| | | |||||||||||||
Forfeited or Expired |
| | | |||||||||||||
Outstanding at December 31, 2007 |
2,013,000 | $ | 2.52 | 3.51 | $ | 716,000 | ||||||||||
Exercisable at December 31, 2007 |
1,352,000 | $ | 2.48 | 3.16 | $ | 714,000 | ||||||||||
| * | The aggregate intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The market value of our stock was $2.01 at December 31, 2007. |
A summary of the status of the Companys non-vested stock options as of December 31, 2007, and
changes during the three months ended December 31, 2007, is presented below:
| Weighted Average | ||||||||
| Grant-Date | ||||||||
| Stock Options | Fair Value | |||||||
Non-vested at October 1, 2007 |
699,000 | $ | 1.72 | |||||
Granted |
25,000 | $ | 1.47 | |||||
Forfeited or Expired |
| | ||||||
Vested |
(63,000 | ) | $ | 1.60 | ||||
Non-vested at December 31, 2007 |
661,000 | $ | 1.73 | |||||
As of December 31, 2007, there was $158,000 of total unrecognized compensation cost related to
non-vested share-based compensation arrangements granted under the stock options plans. That cost
is expected to be recognized over a weighted-average period of 0.57 years. The total fair value of
shares vested during the three months ended December 31, 2007 was $100,000.
Total compensation expense related to outstanding options for the three months ended December
31, 2007 and 2006 was $84,000 and $248,000, respectively. Such amounts are included in selling,
general and administrative expenses in the accompanying Statements of Operations.
Stock warrants The Company recognizes the value of stock warrants issued based upon an
option-pricing model at their fair value as an expense over the period in which the grants vest
from the measurement date, which is the date when number of warrants, their exercise price and
other terms became certain.
At December 31, 2007 and 2006, 3,691,000 and 2,722,000 warrants were outstanding and 2,754,000
and 2,447,000 warrants were vested, respectively.
Total compensation expense related to outstanding warrants for the three months ended December
31, 2007 was $2,000. For the three months ended December 31, 2006 compensation expense was
$33,000.
7
Table of Contents
7. INCOME TAXES
The Company adopted the provisions of FIN 48, Accounting for Uncertainty in Income Taxes an
interpretation of FASB Statement No. 109, (FIN 48), on October 1, 2007. As a result of the
implementation of FIN 48, the Company made a comprehensive review of its portfolio of uncertain tax
positions in accordance with recognition standards established by FIN 48. In this regard, an
uncertain tax position represents the Companys expected treatment of a tax position taken in a
filed tax return, or planned to be taken in a future tax return, that has not been reflected in
measuring income tax expense for financial reporting purposes. As a result of this review, the
Company concluded that at this time there are no uncertain tax positions. As a result of applying
the provisions of FIN 48, there was no cumulative effect on retained earnings at December 31, 2007.
As of December 31, 2007, the Company does not expect any material changes to unrecognized tax
positions within the next twelve months.
SFAS No. 109, Accounting for Income Taxes, establishes financial accounting and reporting
standards for the effect of income taxes. The objectives of accounting for income taxes are to
recognize the amount of taxes payable or refundable for the current year and deferred tax
liabilities and assets for the future tax consequences of events that have been recognized in an
entitys financial statements or tax returns. Judgment is required in assessing the future tax
consequences of events that have been recognized in our financial statements or tax returns.
Fluctuations in the actual outcome of these future tax consequences could materially impact our
financial position or our results of operations.
8. CONTINGENCIES AND OTHER MATTERS
The Company is occasionally subject to legal proceedings and claims that arise in the ordinary
course of business. It is impossible for us to predict with any certainty the outcome of pending
disputes, and we cannot predict whether any liability arising from pending claims and litigation
will be material in relation to our consolidated financial position or results of operations.
9. SUBSEQUENT EVENT
On January 25, 2008, the Company and Bryant Park Capital (BPC) entered into a letter
agreement pursuant to which the Company engaged BPC to act as its exclusive financial advisor and
consultant in connection with a possible merger, acquisition or other similar transaction. The
agreement may be terminated by BPC or the Company after four months upon prior written notice of at
least thirty days. A principal of BPC is the son of Alan Magerman, the Companys Chairman of the
Board of Directors.
Under the agreement, the Company will pay BPC a monthly fee of $10,000. If the Company enters
into a transaction of the type specified in the agreement, the Company will be obligated to pay BPC
a transaction fee that will be determined based upon the size of the transaction, provided that the
minimum transaction fee will be $100,000 and provided that up to $40,000 of monthly fees previously
paid by the Company will be offset against the transaction fee owed by the Company.
8
Table of Contents
| ITEM 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations (rounded in thousands) |
The following discussion and analysis should be read in conjunction with the condensed
consolidated financial statements and accompanying notes filed as part of this report.
Forward-Looking Statements
The following Managements Discussion and Analysis of Financial Condition and Results of
Operations, as well as information contained elsewhere in this report, contain statements that
constitute forward-looking statements within the meaning of Section 27A of the Securities Act of
1933, and Section 21E of the Securities Exchange Act of 1934. These statements include statements
regarding the intent, belief or current expectations of us, our directors or our officers with
respect to, among other things: anticipated financial or operating results, financial projections,
business prospects, future product performance and other matters that are not historical facts. The
success of our business operations is dependent on factors such as the impact of competitive
products, product development, commercialization and technology difficulties, the results of
financing efforts and the effectiveness of our marketing strategies, general competitive and
economic conditions. Forward-looking statements are not guarantees of future performance and
involve risks and uncertainties. Actual results may differ materially from those projected in the
forward-looking statements as a result of various factors.
Results of Operations
Three-months ended December 31, 2007 compared to the three-months ended December 31, 2006
Revenues: We operate in the security lighting systems and night vision industries, and the
majority of our revenues are derived from sales of our illumination products and our new
SuperVision night vision product to various customers.
Revenues for the quarter ended December 31, 2007 were $3,561,000 compared to revenues of
$916,000 for the quarter ended December 31, 2006. In the 2007 quarter, 92% of revenue was from
sales of our NightHunter products to the military (U.S. Army, U.S. Marines and military
distributors). This compares to 83% of revenue to the military market in the same quarter of the
prior year.
Cost of Goods and Gross Profit: Cost of goods consist of the cost of manufacturing our
NightHunter One and SuperVision products and the price that we pay to PerkinElmer for NightHunter
II products that PerkinElmer manufactures for us under a manufacturing agreement.
The gross profit percentage was 49% and 78% for the quarter ended December 31, 2007 and 2006,
respectively. The gross profit percentage was positively impacted in the 2006 quarter by sales of
the NightHunter II product from inventory that was identified as excess inventory in fiscal year
2005. The reduction in the 2006 quarter of the excess inventory reserve related to the sale of
NightHunter II product was $358,000. As of June 30, 2007 all of the excess inventory of the
NightHunter II products had been shipped to customers.
Selling, General and Administrative: Selling, general and administrative expenses increased by
$343,000 to $1,317,000 for the quarter ended December 31, 2007 as compared to $974,000 for the
quarter ended December 31, 2006. The increase is primarily attributed by increases in compensation
from hiring new sales personnel and consulting costs of $102,000; $389,000 for trade show,
advertising, marketing and travel expenses offset by a decrease in non-cash compensation expenses
for stock options and warrants of $195,000.
9
Table of Contents
Engineering, Research & Development: Engineering, research and development expenses were
$139,000 for the quarter ended December 31, 2007 compared to $159,000 for the quarter ended
December 31, 2006. Higher outside engineering expenses were offset by lower compensation costs and
legal expenses for patent filings.
Net Income (Loss): Significantly higher sales in the current quarter accounted for net income
of $312,000 compared to a net loss of $406,000 for the prior year quarter.
Liquidity and Capital Resources
As of December 31, 2007, the Company had working capital of $4,939,000 and a current ratio of
5.7 to 1 as compared to working capital of $4,527,000 and a current ratio of 4.88 to 1 as of
September 30, 2007.
Our net income of $312,000 for the three months ended December 31, 2007 positively impacted
cash. Higher sales in the quarter increased accounts receivable by $3,000,000 and decreased
inventories by $711,000. The majority of the receivables were collected after the end of the
quarter. Non-cash compensation expense for options to employees and issuance of warrants to
consultants during the first three months of the current fiscal year were $86,000. Cash used by
operating activities totaled $2,054,000 for the three months ended December 31, 2007. There were
no cash flows from investing and financing activities during the current quarter.
10
Table of Contents
| ITEM 3. | CONTROLS AND PROCEDURES |
We maintain disclosure controls and procedures that are designed to ensure that information
required to be disclosed in the reports that we file with, or submit to, the Securities and
Exchange Commission (the SEC) under the Securities Exchange Act of 1934 (the Exchange Act) is
recorded, processed, summarized and reported within the time periods specified in the SECs rules
and forms and that such information is accumulated and communicated to our management, including
our principal executive and financial officers, as appropriate, to allow for timely decisions
regarding required disclosure. As required by SEC Rule 13a-15(b), we carried out an evaluation,
under the supervision and with the participation of our management, including our principal
executive and financial officers, of the effectiveness of the design and operation of our
disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this
report.
Based upon the evaluation conducted by management in connection with the audit of the Companys
financial statements for the year ended September 30, 2007, the Company identified material
weaknesses in our internal control over financial reporting. A material weakness is a significant
deficiency, or a combination of significant deficiencies, that results in more than a remote
likelihood that a material misstatement of the annual or interim financial statements will not be
prevented or detected by the Company in a timely manner.
There has been no change in our internal control over financial reporting during our most recent
fiscal quarter that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting. Management has taken steps to correct these material
weaknesses through changes in procedures and personnel.
11
Table of Contents
PART II. OTHER INFORMATION
| ITEM 1. | Legal Proceedings |
The Company is involved in legal actions arising in the normal course of business. After
taking into consideration legal counsels evaluation of such actions, management is of the opinion
that their outcome will not have a significant effect on the Companys financial position or
results of operations.
| ITEM 5. | Other Information |
None.
| ITEM 6. | Exhibits |
| Exhibit | ||
| Number | Description | |
31.1
|
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act | |
31.2
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act | |
32.1
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act |
12
Table of Contents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
| XENONICS HOLDINGS, INC. |
||||
| Date: February 12, 2008 | By: | /s/ Charles W. Hunter | ||
| Charles W. Hunter | ||||
| Chief Executive Officer | ||||
| Date: February 12, 2008 | By: | /s/ Richard S. Kay | ||
| Richard S. Kay | ||||
| Chief Financial Officer | ||||
13